Molecular biologic aspects of cartilage and bone: Potential clinical applications

Upsala Journal of Medical Sciences

Volumn 108, Issue 1, 2003, Pages 25-35

  Engstrand, Thomas ^a,b,c,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b Upsala Medical Association   (Sweden)

^c Amer Soc for Bone and Mineral Res   (United States)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; NOGGIN; OSTEOGENIN; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BONE MARROW; CARTILAGE; CARTILAGE CELL; GENE TARGETING; GENE TRANSFER; GENETIC VARIABILITY; MESENCHYME; MESENCHYME CELL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PERIOSTEUM; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; ANIMAL; ARTICULAR CARTILAGE; BONE; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CARTILAGE, ARTICULAR; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 2142669386     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889-95.
2. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM (1994). Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76:579-92.
3. Amstutz HC, Dorey F, O'Carroll PF (1986). THARIES resurfacing arthroplasty. Evolution and long-term results. Clin Orthop 213:92-114.
4. Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS (1999). Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 81:811-20.
5. Salai M, Horoszowski H, Pritsch M, Amit Y (1999). Primary reconstruction of traumatic bony defects using allografts. Arch Orthop 119:435-9.
6. Engstrand T (2001). Molecular Regulators in Cartilage and Bone formation. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertation from the Faculty of Medicine 1024, 62 pp.
7. Sporn MB RA (1993). The transforming growth factor bs Peptide growth factors and their receptors. Springer-Verlag, New York, pp 419.
8. Erlebacher A, Derynck R (1996). Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210.
9. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R (1999). Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126:4267-79.
10. Ballock RT, Heydemann A, Wakefield LM, Flanders KC, Roberts AB, Sporn MB (1993). TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 158:414-29.
11. Galera P, Redini F, Vivien D, Bonaventure J, Penfornis H, Loyau G, Pujol JP (1992). Effect of transforming growth factor-beta 1 (TGF-beta 1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process. Exp Cell Res 200:379-92.
12. Roberts AB, Heine UI, Flanders KC, Sporn MB (1990). Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann N Y Acad Sci 580:225-32.
13. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988). Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-34.
14. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T (1990). The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172:295-9.
15. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, Rosen V(1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130:1318-24.
16. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991). Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-7.
17. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S, Fujisawa Y (1995). Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210:670-7.
18. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R (1994). Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 126:1595-609.
19. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87:2220-4.
20. Boyne PJ, Marx RE, Kevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P (1997). A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 17:11-25.
21. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H (2000). Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71:1241-57.
22. Geesink RG, Hoefnagels NH, Bulstra SK (1999). Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81:710-8.
23. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D (1997). A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 17:124-39.
24. Piccolo S, Sasai Y, Lu B, De Robertis EM (1996). Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86:589-98.
25. Zimmerman LB, De Jesus-Escobar JM, Harland RM (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606.
26. Benya PD, Shaffer JD (1982). Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30:215-24.
27. Kato Y, Iwamoto M, Koike T, Suzuki F, Takano Y (1988). Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. Proc Natl Acad Sci USA 85:9552-6.
28. Engstrand T, Daluiski A, Bahamonde ME, Melhus H, Lyons KM (2000). Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum Gene Ther 11:205-11.
29. Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB, Woods WI, Reddi AH (1989). Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 264:13377-80.
30. Reddi AH, Muthukumaran N, Ma S, Carrington JL, Luyten FP, Paralkar VM, Cunningham NS (1989). Initiation of bone development by osteogenin and promotion by growth factors. Connect Tissue Res 20:303-12.
31. Vukicevic S, Luyten FP, Reddi AH (1989). Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86:8793-7.
32. Vukicevic S, Helder MN, Luyten FP (1994). Developing human lung and kidney are major sites for synthesis of bone morphogenetic protein-3 (osteogenin). J Histochem Cytochem 42:869-75.
33. Jaatinen R, Rosen V, Tuuri T, Ritvos O (1996). Identification of ovarian granulosa cells as a novel site of expression for bone morphogenetic protein-3 (BMP-3/osteogenin) and regulation of BMP-3 messenger ribonucleic acids by chorionic gonadotropin in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 81:3877-82.
34. Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM (2001). Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 27(1):84-8.
35. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A (2000). Noggin Antagonizes BMP Signaling to Create a Niche for Adult Neurogenesis. Neuron 28:713-726.